Cargando…
Transfusion of pathogen‐reduced platelet components without leukoreduction
BACKGROUND: Leukoreduction (LR) of platelet concentrate (PC) has evolved as the standard to mitigate risks of alloimmunization, clinical refractoriness, acute transfusion reactions (ATRs), and cytomegalovirus infection, but does not prevent transfusion‐associated graft‐versus‐host disease (TA‐GVHD)....
Autores principales: | Sim, Joycelyn, Tsoi, Wai Chiu, Lee, Cheuk Kwong, Leung, Rock, Lam, Clarence C. K., Koontz, Claudia, Liu, Amy Yingjie, Huang, Norman, Benjamin, Richard J, Vermeij, Hans J., Stassinopoulos, Adonis, Corash, Laurence, Lie, Albert K. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850058/ https://www.ncbi.nlm.nih.gov/pubmed/30919465 http://dx.doi.org/10.1111/trf.15269 |
Ejemplares similares
-
Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia
por: Aydinok, Yesim, et al.
Publicado: (2019) -
Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
por: Bahar, Burak, et al.
Publicado: (2019) -
Cost implications of implementation of pathogen-inactivated platelets
por: McCullough, Jeffrey, et al.
Publicado: (2015) -
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components
por: Snyder, Edward L., et al.
Publicado: (2022) -
The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion‐induced red blood cell alloimmunisation
por: Oud, Josine A., et al.
Publicado: (2021)